Acute myocardial infarction in the elderly

American Journal of Geriatric Cardiology

Volumn 9, Issue 3, 2000, Pages 138-144

  Reardon, M ^a   Camm, J A ^a  

^a WORTHING HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENCAINIDE; FIBRINOLYTIC AGENT; FLECAINIDE; HEPARIN; LISINOPRIL; LOW MOLECULAR WEIGHT HEPARIN; METOPROLOL; MORACIZINE; NITRATE; RAMIPRIL; STREPTOKINASE; VERAPAMIL;

ACUTE HEART INFARCTION; AGING; BRAIN HEMORRHAGE; CLINICAL TRIAL; DOSE RESPONSE; DRUG CHOICE; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; FIBRINOLYTIC THERAPY; GASTROINTESTINAL HEMORRHAGE; GERIATRIC PATIENT; HUMAN; META ANALYSIS; MORTALITY; PROPHYLAXIS; REVIEW; TREATMENT OUTCOME;

EID: 0033846687     PISSN: 10767460     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1076-7460.2000.80023.x     Document Type: Review

References (42)

1. Age-related mortality, clinical heart failure and ventricular fibrillation in 4259 Danish patients after acute myocardial infarction
2. Changing presentation of myocardial infarction with increasing old age
3. The elderly in a coronary care unit
4. The influence of age on policies for admission and thrombolysis in coronary units in the UK
5. The exclusion of the elderly and women from clinical trials in acute myocardial infarction
6. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
7. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction
8. Adverse effects of low-dose aspirin in an elderly population
9. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction
10. Adherence to national guidelines for drug therapy of suspected acute myocardial infarction: Evidence for under treatment in women and the elderly
11. Relationship of age with eligibility for thrombolytic therapy and mortality among patients with suspected acute myocardial infarction
12. Cerebrovascular events after myocardial infarction: Analysis of the GISSI trial
13. Cerebrovascular accident complicating acute myocardial infarction: Incidence, clinical significance and short and long term mortality rates
14. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
15. Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction
16. ISIS-3 A randomised trial of streptokinase vs tissue plasminogen activators anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction
17. Randomised trial of late thrombolysis in patients with acute myocardial infarction
18. Late assessment of thrombolytic efficacy study with alteplase 6-24 hours after onset of acute myocardial infarction
19. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
20. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
21. Utility of beta-blockade treatment for older post infarction patients
22. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction
23. Randomized trial of intravenous atenolol among 16,027 cases of suspected myocardial infarction
24. Effect on mortality of metoprolol in acute myocardial infarction: A double-blind randomised trial
25. Metoprolol in acute myocardial infarction: A randomised placebo- controlled international trial
26. Immediate vs deferred β-blockade following thrombolytic therapy in patients with myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 11B study
27. Comparison of invasive and conservative strategies after treatment with intravenous tPA in acute myocardial infarction
28. Timolol-related reduction in mortality and reinfarction in patients ages 65-75 years surviving acute myocardial infarction
29. Six year follow-up of the Norwegian Multicentre Study on timolol after myocardial infarction
30. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6 week mortality and ventricular function after acute myocardial infarction
31. A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction
32. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
33. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival And Ventricular Enlargement (SAVE) trial
34. ACC/AHA guidelines for the early management of patients with acute myocardial infarction
35. Diltiazem and reinfarction in patients with non-Q wave myocardial infarction: Results of a double blind, randomized, multicentre trial
36. Effect of verapamil on mortality and major events after myocardial infarction (DAVIT 11)
37. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: An overview of results from randomized controlled trials
38. Mortality and morbidity in patients receiving encainide, flecainide or placebo. The Cardiac Arrhythmia Suppression Trial
39. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction
40. Effect of prophylactic amiodarone on mortality after myocardial infarction and in congestive heart failure: Metaanalysis of individual data from 6500 patients in randomized trials
41. Age related outcome in acute myocardial infarction: Elderly people benefit from thrombolysis and should be included in trials
42. How should age affect management of acute myocardial infarction? A prospective cohort study